Nishizawa S, Chen D, Yokoyama T, Yokota N, Otha S
Department of Neurosurgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Acta Neurochir (Wien). 2000;142(12):1409-15. doi: 10.1007/s007010070013.
Endothelium plays a role in the regulation of vascular tone. Endothelin is a family of potent vasoconstrictive peptides, and endothelin-1 (ET-1) produced in the endothelium induces a tonic contraction via specific receptor ET(A). ET-1 has been postulated as an important factor in the development of vasospasm after subarachnoid haemorrhage (SAH). We have previously shown that protein kinase C (PKC) of the cerebral artery plays a pivotal role in the pathogenesis of vasospasm. The purpose of this study is to clarify the relationship between ET-1 and PKC in the development and maintenance of vasospasm. Using a "two-haemorrhage" canine model, chronological changes of angiographic progression of vasospasm, PKC activation, and ET-1 level of the basilar artery were assessed. In an isometric tension study with a control artery, the effects of ET(A)- and ET(A)/ET(B)-antagonists on the tonic contraction induced by ET-1 were examined. The effects of ET-1, ET-1 and an ET(A)-antagonist, and ET-1 and an ET(A)/ET(B)-antagonist on PKC activation were also evaluated. ET-1 level temporarily increased, then decreased to the control level in a later stage of vasospasm. ET-1 induced a tonic contraction and enhancement of PKC activation, but both were inhibited either by an ET(A)- or an ET(A)/ET(B)-antagonist. These results indicate that ET-1 initiates the development of vasospasm through PKC activation, but does not contribute to prolonged vasospasm.
内皮细胞在血管张力调节中发挥作用。内皮素是一族强效血管收缩肽,内皮细胞产生的内皮素-1(ET-1)通过特异性受体ET(A)诱导持续性收缩。ET-1被认为是蛛网膜下腔出血(SAH)后血管痉挛发生发展的一个重要因素。我们之前已经表明,脑动脉中的蛋白激酶C(PKC)在血管痉挛的发病机制中起关键作用。本研究的目的是阐明ET-1与PKC在血管痉挛发生发展及维持过程中的关系。使用“两次出血”犬模型,评估血管痉挛的血管造影进展、PKC激活以及基底动脉ET-1水平的时间变化。在对照动脉的等长张力研究中,检测ET(A)拮抗剂和ET(A)/ET(B)拮抗剂对ET-1诱导的持续性收缩的影响。还评估了ET-1、ET-1与ET(A)拮抗剂以及ET-1与ET(A)/ET(B)拮抗剂对PKC激活的影响。ET-1水平在血管痉挛后期暂时升高,然后降至对照水平。ET-1诱导持续性收缩并增强PKC激活,但两者均被ET(A)拮抗剂或ET(A)/ET(B)拮抗剂抑制。这些结果表明,ET-1通过激活PKC启动血管痉挛的发生,但对血管痉挛的持续存在没有作用。